Tdark | Acylphosphatase-1 |
Its physiological role is not yet clear.
This gene is a member of the acylphosphatase family. The encoded protein is a small cytosolic enzyme that catalyzes the hydrolysis of the carboxyl-phosphate bond of acylphosphates. Two isoenzymes have been isolated and described based on their tissue localization: erythrocyte (common) type acylphosphatase encoded by this gene, and muscle type acylphosphatase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
This gene is a member of the acylphosphatase family. The encoded protein is a small cytosolic enzyme that catalyzes the hydrolysis of the carboxyl-phosphate bond of acylphosphates. Two isoenzymes have been isolated and described based on their tissue localization: erythrocyte (common) type acylphosphatase encoded by this gene, and muscle type acylphosphatase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
Comments
Disease | Target Count | P-value |
---|---|---|
Pick disease | 1893 | 1.19987039698106E-4 |
pilocytic astrocytoma | 3086 | 1.30192869144501E-4 |
adult high grade glioma | 2148 | 3.31861662142777E-4 |
osteosarcoma | 7933 | 6.48912293908813E-4 |
lung cancer | 4473 | 9.25942786478656E-4 |
intraductal papillary-mucinous carcinoma (IPMC) | 2988 | 0.00125151052393787 |
glioblastoma | 5572 | 0.00382454270426233 |
intraductal papillary-mucinous adenoma (IPMA) | 2956 | 0.0041140242873979 |
intraductal papillary-mucinous neoplasm (IPMN) | 3289 | 0.00547808988076976 |
astrocytic glioma | 2241 | 0.0161891797966141 |
ovarian cancer | 8492 | 0.0203366198674563 |
aldosterone-producing adenoma | 664 | 0.025503673335229 |
Disease | log2 FC | p |
---|---|---|
astrocytic glioma | -1.300 | 0.016 |
osteosarcoma | -1.758 | 0.001 |
glioblastoma | -1.300 | 0.004 |
intraductal papillary-mucinous adenoma (... | 1.200 | 0.004 |
intraductal papillary-mucinous carcinoma... | 1.700 | 0.001 |
intraductal papillary-mucinous neoplasm ... | 2.000 | 0.005 |
lung cancer | 1.600 | 0.001 |
adult high grade glioma | -1.300 | 0.000 |
pilocytic astrocytoma | -1.300 | 0.000 |
aldosterone-producing adenoma | -1.068 | 0.026 |
Pick disease | -1.300 | 0.000 |
ovarian cancer | 1.300 | 0.020 |
Species | Source |
---|---|
Chimp | OMA EggNOG |
Macaque | OMA EggNOG |
Mouse | OMA EggNOG Inparanoid |
Rat | OMA EggNOG Inparanoid |
Dog | OMA EggNOG |
Horse | OMA EggNOG Inparanoid |
Cow | OMA EggNOG Inparanoid |
Pig | OMA EggNOG Inparanoid |
Opossum | EggNOG Inparanoid |
Chicken | OMA EggNOG Inparanoid |
Anole lizard | OMA EggNOG Inparanoid |
Xenopus | OMA EggNOG Inparanoid |
Fruitfly | EggNOG Inparanoid |
PMID | Text |
---|---|
14992377 | two products of the ACYP1 gene are characterized as the result of alternative splicing in which an extra 79 bp long exon is inserted between the two known exons |
12409302 | Data show that CT acylphosphatase catalyzes the hydrolysis of aryl phosphates and acyl phosphates by two different mechanisms. |
PMID | Year | Title |
---|---|---|
23376485 | 2013 | Proteomic analysis of podocyte exosome-enriched fraction from normal human urine. |
21269460 | 2011 | Initial characterization of the human central proteome. |
19196981 | 2009 | Rational stabilization of enzymes by computational redesign of surface charge-charge interactions. |
16511269 | 2006 | Crystallization and preliminary crystallographic analysis of human common-type acylphosphatase. |
15489334 | 2004 | The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
14992377 | 2004 | ACYP1 gene possesses two alternative splicing forms that induce apoptosis. |
14702039 | 2004 | Complete sequencing and characterization of 21,243 full-length human cDNAs. |
12508121 | 2003 | The DNA sequence and analysis of human chromosome 14. |
12477932 | 2002 | Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |
12409302 | 2003 | A nucleophilic catalysis step is involved in the hydrolysis of aryl phosphate monoesters by human CT acylphosphatase. |
More... |